logo
ProtagonistandTakedaPresentLonger-TermDataatASH2025ShowingRusfertideDeliversDurableResponseandHematocritControlinPolycythemiaVera
===2025/12/8 11:31:44===
oking statements that we make in this press release speak only as of the date of this press release. We assume no obligation to update our forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this press release.

Takeda Important Notice
For the purposes of this notice, “press release” means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda”) regarding this release. This press release (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not constitute, represent or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, exchange, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction. No shares or othe
=*=*=*=*=*=
当前为第16/23页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页